multiple foods

Read news on multiple foods with our app.

Read more in the app

Omalizumab, a recombinant humanized IgG1 monoclonal antibody, reduces allergic reactions to multiple foods in NIH trial. This could expand the amount of different common foods that children with food allergies can safely consume without eliciting an allergic reaction.